Cargando…

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate

Background: C-X-C motif chemokine ligand 13 (CXCL13), a member of the CXC subtype in chemokine superfamily, affects numerous biological processes of various types of cells and the progress of a great number of clinical diseases. The purpose of the current study was to reveal the internal mechanism b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Daoquan, Li, Mingzhou, Fu, Xun, Yang, Shu, Wang, Zhen, Liu, Jianmin, Li, Yan, Zhou, Yongying, Ren, Pengfei, Guo, Yuhang, Wang, Xinghuan, DiSanto, Michael E., Chen, Ping, Zhang, Xinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820459/ https://www.ncbi.nlm.nih.gov/pubmed/36613500 http://dx.doi.org/10.3390/ijms24010056

Ejemplares similares

Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate
por: Fu, Xun, et al.
Publicado: (2022)

Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate
por: Xiao, He, et al.
Publicado: (2020)

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate
por: Li, Yan, et al.
Publicado: (2023)

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
por: Li, Zhuo, et al.
Publicado: (2018)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain
por: Wang, Shi-Feng, et al.
Publicado: (2016)

The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities
por: Fu, Xun, et al.
Publicado: (2022)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway
por: Wang, Zhen, et al.
Publicado: (2023)

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
por: Zhou, Yongying, et al.
Publicado: (2021)

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia
por: Liu, Jianmin, et al.
Publicado: (2021)

Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer
por: Luo, Xiaofan, et al.
Publicado: (2022)

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
por: Li, Chunyan, et al.
Publicado: (2015)

Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Liang, Minrui, et al.
Publicado: (2016)

Alterations in the phosphodiesterase type 5 pathway and oxidative stress correlate with erectile function in spontaneously hypertensive rats
por: He, Weixiang, et al.
Publicado: (2020)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
por: Dersch, R, et al.
Publicado: (2015)

The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis
por: Henningsson, Anna J., et al.
Publicado: (2018)

The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
por: Zhang, Xu, et al.
Publicado: (2023)

Changes in the expression and function of the PDE5 pathway in the obstructed urinary bladder
por: He, Weixiang, et al.
Publicado: (2020)

Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
por: Zhang, Wenhao, et al.
Publicado: (2015)

Chemokine (C‐X‐C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid‐derived suppressor cells
por: Shi, Huifang, et al.
Publicado: (2018)

Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses
por: Lv, Qi-yuan, et al.
Publicado: (2021)

CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients
por: Zeng, Yan-Li, et al.
Publicado: (2016)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

Type-I Interferons Suppress Microglial Production of the Lymphoid Chemokine, CXCL13
por: Esen, Nilufer, et al.
Publicado: (2014)

Elevated Plasma Levels of CXCL13 Chemokine in Saudi Patients With Asthma Exacerbation
por: Alturaiki, Wael
Publicado: (2022)

Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels
por: Jones, Jonathan D, et al.
Publicado: (2014)

Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse
por: Kim, Jinhyun, et al.
Publicado: (2014)

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
por: Yan, Yali, et al.
Publicado: (2022)

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
por: DiSano, Krista D., et al.
Publicado: (2021)

Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles
por: Shan, Shidong, et al.
Publicado: (2023)

An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients
por: Gu, Linping, et al.
Publicado: (2021)

An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13
por: Zhang, Huanyu, et al.
Publicado: (2022)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015)

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
por: Panse, J, et al.
Publicado: (2008)

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
por: Wang, Gui-Zhen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lkl54pckmgu5vf01210hst6ug4